Hem › Icke-muskelinvasiv blåscancer › North Carolina
Kliniska studier för Icke-muskelinvasiv blåscancer i North Carolina
6 studier för Icke-muskelinvasiv blåscancer söker deltagare vid platser i North Carolina.
Städer i North Carolina
Officiell studietext (engelska)
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
- Duke Cancer Institute, Durham
- Associate Urologist of North Carolina, Raleigh
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 29 sep. 2026 · NCT06995677A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
- Biorepository and Precision Pathology Center (BRPC), Durham
- Duke Cancer Institute, Durham
- Substrate Services Core Research Support (SSCRS), Durham
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT07206225A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
- Urology Specialists of the Carolinas PLLC Charlotte, Charlotte
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07309445FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- University of North Carolina (UNC) - Chapel Hill, Chapel Hill
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 20 aug. 2026 · NCT05614739LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- UNC Chapel Hill Hospital, Chapel Hill
- Duke Health - Duke Cancer Center, Durham
- Associated Urologists of North Carolina, Raleigh
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 7 aug. 2026 · NCT04752722Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
- University of North Carolina, Chapel Hill
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 31 juli 2026 · NCT07225127Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.